John Ku increased its stake in Prestige Brands Hldgs Inc (PBH) by 22.24% based on its latest 2017Q3 regulatory filing with the SEC. Manor Road Capital Partners Llc bought 895,000 shares as the company’s stock declined 12.04% while stock markets rallied. The hedge fund run by John Ku held 4.92 million shares of the health care company at the end of 2017Q3, valued at $246.44M, up from 4.03 million at the end of the previous reported quarter. Manor Road Capital Partners Llc who had been investing in Prestige Brands Hldgs Inc for a number of months, seems to be bullish on the $1.80B market cap company. The stock increased 0.27% or $0.09 during the last trading session, reaching $33.85. About 849,960 shares traded or 18.39% up from the average. Prestige Brands Holdings, Inc. (NYSE:PBH) has declined 8.57% since February 13, 2017 and is downtrending. It has underperformed by 25.27% the S&P500.
Ing Groep Nv decreased its stake in Abbott Labs (ABT) by 57.92% based on its latest 2017Q3 regulatory filing with the SEC. Ing Groep Nv sold 16,768 shares as the company’s stock declined 3.42% while stock markets rallied. The institutional investor held 12,180 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $650,000, down from 28,948 at the end of the previous reported quarter. Ing Groep Nv who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $99.93 billion market cap company. The stock increased 0.42% or $0.24 during the last trading session, reaching $57.41. About 8.23 million shares traded or 17.89% up from the average. Abbott Laboratories (NYSE:ABT) has risen 15.90% since February 13, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.
Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It worsened, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Nikko Asset Mngmt Americas holds 2,600 shares or 0.01% of its portfolio. Warren Averett Asset Mngmt Ltd owns 13,092 shares. Spark Investment Mgmt Ltd Liability holds 0.01% or 4,000 shares. Spectrum Mgmt Gp holds 0% or 32 shares in its portfolio. Loring Wolcott Coolidge Fiduciary Limited Liability Partnership Ma invested in 2.11M shares. State Common Retirement Fund reported 4.70 million shares. The Switzerland-based Swiss Bank & Trust has invested 0.41% in Abbott Laboratories (NYSE:ABT). Dock Street Asset Mngmt Inc invested in 40,021 shares or 0.93% of the stock. Garrison Financial Corp reported 3.05% stake. Alphamark, a Kentucky-based fund reported 100 shares. Westfield Cap Management LP reported 2.33 million shares or 0.95% of all its holdings. Barnett & Inc holds 0.02% of its portfolio in Abbott Laboratories (NYSE:ABT) for 625 shares. 186,781 are held by Tiverton Asset Management Ltd Liability Corp. 4.32 million are owned by Fayez Sarofim And Com. Essex Financial Inc invested 0.39% in Abbott Laboratories (NYSE:ABT).
Since August 16, 2017, it had 0 insider buys, and 7 selling transactions for $31.71 million activity. Fussell Stephen R also sold $14.27 million worth of Abbott Laboratories (NYSE:ABT) shares. Ford Robert B sold $2.69M worth of stock or 42,665 shares. On Wednesday, January 31 the insider Blaser Brian J sold $1.73 million. Contreras Jaime sold $2.74M worth of stock.
Ing Groep Nv, which manages about $5.88B and $5.19 billion US Long portfolio, upped its stake in United States Oil Fund Lp (USO) by 535,400 shares to 622,195 shares, valued at $6.49 million in 2017Q3, according to the filing. It also increased its holding in Synopsys Inc (NASDAQ:SNPS) by 5,277 shares in the quarter, for a total of 12,984 shares, and has risen its stake in Price T Rowe Group Inc (NASDAQ:TROW).
Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. Morgan Stanley maintained it with “Equal-Weight” rating and $4 target in Tuesday, July 11 report. Morgan Stanley upgraded the shares of ABT in report on Tuesday, January 2 to “Overweight” rating. RBC Capital Markets maintained Abbott Laboratories (NYSE:ABT) rating on Friday, September 1. RBC Capital Markets has “Buy” rating and $55.0 target. BMO Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Monday, October 2 with “Hold” rating. On Monday, April 17 the stock rating was maintained by Cowen & Co with “Buy”. As per Thursday, July 20, the company rating was maintained by BMO Capital Markets. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, April 19. The firm has “Buy” rating by Deutsche Bank given on Friday, July 21. Wells Fargo maintained the shares of ABT in report on Thursday, September 28 with “Buy” rating. Morgan Stanley downgraded Abbott Laboratories (NYSE:ABT) on Monday, January 4 to “Equal-Weight” rating.
Among 10 analysts covering Prestige Brands Holdings (NYSE:PBH), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Prestige Brands Holdings had 24 analyst reports since August 11, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Friday, February 5 by Piper Jaffray. The stock has “Outperform” rating by Raymond James on Monday, May 22. The firm has “Buy” rating given on Monday, September 4 by KeyBanc Capital Markets. Zacks upgraded Prestige Brands Holdings, Inc. (NYSE:PBH) rating on Tuesday, August 11. Zacks has “Hold” rating and $54 target. The stock of Prestige Brands Holdings, Inc. (NYSE:PBH) has “Buy” rating given on Thursday, November 17 by Gabelli. The firm earned “Hold” rating on Wednesday, August 12 by Jefferies. The firm earned “Buy” rating on Tuesday, December 27 by B. Riley & Co. The stock has “Overweight” rating by KeyBanc Capital Markets on Monday, February 5. The rating was downgraded by DA Davidson on Monday, February 5 to “Neutral”. The stock of Prestige Brands Holdings, Inc. (NYSE:PBH) earned “Buy” rating by DA Davidson on Thursday, October 12.